Both drug classes were equally effective in reducing combined major adverse cardiac events such as heart attack, stroke, and death from cardiovascular disease, compared to people with diabetes who were not taking the drugs.[3] The rate of hospitalization for heart failure was 32% less in patients taking SGLT2 inhibitors compared to patients not taking the drugs, especially in those with more severe cardiovascular disease risk
Systematic reviews of glutathione supplementation show no significant effect on body weight, BMI, or waist circumference
Anyone who becomes pregnant while on tirzepatide should discontinue it immediately and consult their OB-GYN
These may include nausea, bloating, or diarrhea
Suppressing glucagon: By reducing the amount of glucagon, a hormone that raises blood sugar levels, they help maintain glucose stability